DiaMedica Therapeutics Inc. (DMAC) Return on equity

DiaMedica Therapeutics Inc. (DMAC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.

-62.5%FY2019

Fiscal year	Value	YoY
FY2019	-62.5%	—

ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).

Source: SEC XBRL filings · For reference only · Not investment advice

More DMAC financial trends

DMAC Revenue DMAC Net income DMAC Net margin DMAC Gross profit DMAC Gross margin DMAC Operating income DMAC Operating margin DMAC Operating cash flow DMAC Free cash flow DMAC Capital expenditures DMAC Stock buybacks DMAC Dividends paid DMAC Total assets DMAC Total liabilities DMAC Shareholders’ equity DMAC overview →